STROMA THERAPEUTICS LIMITED
Significant control: Paul Alexandre De Sousa (25–50%), Aidan Benedict Courtney (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Stroma Therapeutics Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Stroma Therapeutics Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
STROMA THERAPEUTICS LIMITED is an active private limited company (company number SC657504) incorporated on 16 March 2020, registered in Edinburgh. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 30 June 2025, showing net assets of −£8,288 and cash of £10k, with 0 employees on average. Net assets fell 16% on the prior period (−£7,148).
By net assets it sits in the bottom quarter of 62 comparable companies in Edinburgh (median £4,168, upper quartile £51k).
Ownership and control
- Dr Paul Alexandre De Sousa
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Mr Aidan Benedict Courtney
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 16 March 20206 yrs ago
- Next accounts due
- 30 March 2027in 155 days
- Confirmation statement due
- 30 March 2027in 155 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 June 2025 | −£8,288 | £10k | — | £21k | — | — | 0 |
| 30 June 2024 | −£7,148 | £14k | — | £24k | — | — | 0 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets below zeroNet assets £-8,288 at 30 June 2025
- Current assets below creditors within one yearCurrent ratio 0.53
- Incorporated five or more years agoIncorporated 16 March 2020
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 155 days
- Confirmation statement duein 155 days
- Accounts period endNet liabilities £8,288 · small accounts
- Accounts period endNet liabilities £7,148 · small accounts
- Incorporated
Similar companies in Edinburgh
- NODUS ONCOLOGY LIMITEDEdinburgh · inc. Apr 2020
- DYNEVAL LIMITEDEdinburgh · inc. Apr 2020
- MPW INTERNATIONAL LTDEast Saltoun · inc. Jan 2020
- EPIDAREX EXEED LIMITEDEdinburgh · inc. Aug 2019
- ALGACRAFT LTDEdinburgh · inc. Aug 2019
- PROZYMI BIOLABS LTDEdinburgh · inc. Feb 2021
All companies incorporated on 16 March 2020 · in Mar 2020.
Reminders for STROMA THERAPEUTICS LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.